John H.
- Country
- Ireland
- Department
- D10-515 : Nephrology
Research Overview
- A Phase 2b/3 Adaptive, Randomized, Active controlled Study Evaluating the Efficacy, Safety, and Tolerability of Povetacicept Versus Calcineurin Inhibitor in the Treatment of Primary Membranous Nephropathy
- Efficacy and Safety Evaluation of Atacicept in Adult Patients with IgA Nephropathy: A Phase 2b/3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 8 of 47 partner sites.
Specializations
Nephrology Focus
This investigator specializes in the study of IgA Nephropathy, a specific form of kidney disease affecting the glomeruli. Their research concentrates on evaluating innovative therapeutic approaches for managing this chronic kidney condition.
- Glomerular Diseases
- Proteinuria Management
- Kidney Disease Progression
The investigator's work centers on examining therapeutic interventions that may help reduce protein excretion in patients with kidney disorders.
Immunological Research
Their research extends into immunological aspects of kidney disease, particularly focusing on targeted therapeutic approaches that modulate immune responses in renal conditions.
- Immune-Mediated Kidney Disorders
- Immunoglobulin Research
- Novel Therapeutic Approaches
The investigator explores the relationship between immune system responses and kidney disease manifestations.
Clinical Applications
The investigator's work encompasses therapeutic innovation in nephrology, with particular attention to developing treatments for chronic kidney conditions.
- Disease Modification Strategies
- Renal Function Preservation
- Treatment Response Assessment
Their research aims to advance understanding of treatment efficacy in kidney disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.